Author

Andrea Spannheimer

Observed names: A SPANNHEIMER, A Spannheimer, A. Spannheimer

OpenAlex ID: A5028616705

Kosten des Typ-2-Diabetes in Deutschland

2001 · A Liebl, A Neiß, et al. · DMW - Deutsche Medizinische Wochenschrift · 113

Complications, co-morbidity, and blood glucose control in type 2 diabetes mellitus patients in Germany - results from the CODE-2TM study

2002 · A. Liebl, A. Neiss, et al. · Experimental and Clinical Endocrinology & Diabetes · 87

Comparison of Therapies With Torasemide or Furosemide in Patients With Congestive Heart Failure From a Pharmacoeconomic Viewpoint

1998 · A Spannheimer, A Goertz, et al. · International Journal of Clinical Practice · 41

PDF

Kosten für Spätkomplikationen bei Diabetes mellitus Typ 2 in Deutschland

2002 · Andreas Liebl, Andrea Spannheimer, et al. · Medizinische Klinik - Intensivmedizin und Notfallmedizin · 29

Bootstrap Confidence Intervals for Costs-of-Illness of Type 2 Diabetes Mellitus in Germany

2002 · Stefan Wagenpfeil, Albrecht Neiss, et al. · Value in Health · 7

PDF

Kostenanalyse der Schizophrenie-Behandlung in Deutschland - Vergleich von Olanzapin, Risperidon und Haloperidol mit Hilfe eines klinischen Entscheidungsmodells -

2001 · C. Deckert, J. Höffler, et al. · Gesundheitsökonomie & Qualitätsmanagement · 7

Length of hospital stay and associated costs for olanzapine vs. haloperidol in the treatment of schizophrenia relapse in Germany

2003 · U. Reitberger, A. Spannheimer, et al. · The European Journal of Health Economics · 5

[Costly type 2 diabetes mellitus. Does diabetes cost 20 billion per year?].

2000 · A Liebl, A Goertz, et al. · PubMed · 5

Ed3: Dealing With Co-morbidity and Rare Complications in a Diabetes Type 2 Cost of Illness Study

1999 · A Spannheimer, A Goertz, et al. · Value in Health · 3

PDF

Pcn3: Cost Analysis of Schizophrenia Treatment in Germany: a Comparison of Olanzapine, Risperidone, and Haloperidol Using a Clinical Decision Model

1999 · A Spannheimer, J Clouth, et al. · Value in Health · 3

PDF

Pmh12 Patient and Disease Characteristics in Schizophrenia Outpatients and Inpatients Treated With Olanzapine and Haloperidol in Germany: Results From the Geo Observational Study

2002 · F Eichmann, U Reitberger, et al. · Value in Health · 2

PDF

PCV7 Economic Evaluation of Torasimide in Congestive Heart Failure in Germany

1998 · A Spannheimer, A Goertz · Value in Health · 2

Prp13 Costs of Copd in Germany—results of a Cost-of Illness Study

2003 · A Spannheimer, C Schlegel, et al. · Value in Health · 1

Pcv33: Cost-analysis of Cabg Surgery in Patients With and Without Rethoracotomy From the Hospital Perspective in Germany

2001 · A Spannheimer, O Mast, et al. · Value in Health · 1

PDF

The lower the quality of life the higher health care costs in irritable Bowel syndrome

2001 · P ENCK, P ILGENSTEIN, et al. · Gastroenterology · 1

Pin16 Economic Burden and Factors Influencing Costs in German Patients Hospitalised for Communityacquired Pneumonia (cap)

2004 · S Decker-Burgard, M Ehrnsperger, et al. · Value in Health

PDF

Pgi3 Cost-effectiveness of Esomeprazole Compared to Pantoprazole and Generic Omeprazole in Endoscopy Positive Gerd Patients in Germany

2004 · M Gross, S Braun, et al. · Value in Health

PDF

Pmh11 Antipsychotic Medication Patterns in Schizophrenia Outpatients and Inpatients Treated With Olanzapine and Haloperidol in Germany: Results From the Geo Observational Study

2002 · F Eichmann, U Reitberger, et al. · Value in Health

Hospitalisation and costs for schizophrenia relapse treatment in Germany

2002 · A. Spannheimer, U. Reitberger, et al. · European Psychiatry

Pdg16: Budgetary Impact of Treatment Guidelines—the Example of Type 2 Diabetes

2001 · O Pirk, A Goertz, et al. · Value in Health

PDF

Pdg13: Assessing Patient Care and Cost of Patients With Type 2 Diabetes in Germany—an Analysis Across Different Treatment Types

2001 · A Goertz, A Spannheimer, et al. · Value in Health

Php19: Cost of Blood Products in German Hospitals

2001 · A Spannheimer, O Mast, et al. · Value in Health

Comparison of hospital stays due to a relapse of schizophrenia in Germany by means of hospital chart review: Olanzapine versus haloperidol

2001 · A. Spannheimer, U. Reitberger, et al. · European Neuropsychopharmacology

Pgu1o: Irritable Bowel Syndrome (ibs) in Germany: a Cost of Illness Study

2000 · O Pirk, FU Fricke, et al. · Value in Health

PDF

Pdb1: Resource Use and Cost Associated With Micro- and Macrovascular Complications in Patients With Type 2 Diabetes

2000 · A Goertz, A Spannheimer, et al. · Value in Health

Works count: 26

Citation count: 307

H-index: 6

I10-index: 4